| INTRODUCTION
Photoallergic contact dermatitis is a delayed-type hypersensitivity reaction that occurs when an exogenous agent (photoallergen) is applied to the skin and subsequently exposed to ultraviolet (UV) and/ or visible radiation. 1 Historically, several agents have been identified as photoallergens. Currently, the 2 most common groups of photoallergens are organic UV absorbers used in sunscreens and topical nonsteroidal anti-inflammatory drugs (NSAIDs). The frequency of positive photopatch test reactions is unknown, but they are thought to be uncommon, with frequencies of 2%-10% having been reported among patients referred for investigation of dermatitis on photoexposed skin.
The investigation of choice for the diagnosis of photoallergic contact dermatitis is photopatch testing. 2 In 2012, a consensus photopatch test series was established on the basis of the results of a European multicentre study 3 that was conducted in 30 different hospitals between 2008 and 2011, on previous publications reporting photoallergy and on the presence or absence of these agents in consumer products within the European market. 4, 5 Twenty substances were chosen to constitute the European photopatch test baseline series, and 15 additional substances that might be important to study in selected cases were recommended to be included in an extended photopatch test series. 6 The European photopatch test series has been routinely tested in our department since May 2014 in patients referred for photopatch testing. The aim of this study was to analyse the data from patients who underwent photopatch testing with the European series at our department during the period between May 2014 and December 2016. Among the patients who had been photopatch tested, a total of Concerning the groups of (photo)allergens, NSAIDs were the most frequent allergens in our study (51 positive reactions in 27 patients). Etofenamate also elicited many positive patch test reactions, being the leading patch test allergen, which may suggest that it has photoallergenic and allergenic properties. 13, 14 patch test reactions to decyl glucoside were found, but not to pure MBBT. This stresses the importance of individually including the surfactant and the pure sunscreen in the photopatch test, as in our study. [18] [19] [20] Fenofibrate reactions were of uncertain relevance in all positive patients, and co-sensitization with other allergens such as ketoprofen, octocrylene and benzophenone-3 was found, which is why we consider fenofibrate reactions to be cross-reactions.
| METHODS
It has to be emphasized that the patch test baseline series should also be tested when suspected "sun-exposed dermatitis" is investigated, because (photoaggravated) allergic contact dermatitis, for example, to isothiazolinones can mimic photoallergic contact dermatitis, as shown in our patients and as previously described in the literature. [21] [22] [23] [24] [25] [26] [27] [28] In conclusion, our results are in accordance with those published for the consensus photopatch test series. They confirm the usefulness of the European photopatch test baseline series.
